| Literature DB >> 31446024 |
Juanjuan Zhao1, Jun Yang2, Yan Xie3.
Abstract
Although flavonoid compounds have various pharmacological applications, they generally exhibit low oral bioavailability due to their poor aqueous solubility. To address this problem, numerous promising strategies, such as the use of an absorption enhancer, structural transformation (e.g., prodrugs, glycosylation), and pharmaceutical technologies (e.g., carrier complexes, nanotechnology, cocrystals), have been developed and applied to deliver poorly water-soluble flavonoids. These formulation approaches can effectively improve the oral bioavailability of flavonoids by enhancing their solubility, dissolution rate and permeability; preventing their degradation or metabolism in the gastrointestinal tract; and/or delivering them directly to their physiological targets. This review comprehensively summarizes the viable oral delivery systems for insoluble flavonoids to date and discusses their design principles, potential advantages, possible limitations, and oral delivery efficiency, which will provide some useful clues and references to overcome the absorption barrier of these insoluble flavonoids.Entities:
Keywords: Absorption enhancers; Chitosan (PubChem CID16213812); Daidzein (PubChem CID5281708); Flavonoids; Isoniazid (PubChem CID3767); Isorhamnetin (PubChem CID5281654); Kaempferol (PubChem CID5280863); Myricetin (PubChem CID5281672); Nicotinamide (PubChem CID936); Oral bioavailability; Pharmaceutical technologies; Phytic acid (PubChem CID890); Quercetin (PubChem CID5280343); Structural transformation; β-Cyclodextrin (PubChem CID444041)
Mesh:
Substances:
Year: 2019 PMID: 31446024 DOI: 10.1016/j.ijpharm.2019.118642
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875